BioSpace News Archive

Business

Innoviva Reports Third Quarter 2019 Financial Results

Innoviva, Inc. (NASDAQ: INVA) (the “Company”) today reported financial results for the third quarter ended September 30, 2019.

October 30, 2019
·
10 min read
Business

QIAGEN Reports Full Results for Third Quarter and First Nine Months of 2019

QIAGEN N.V. announced results of operations for the third quarter and first nine months of 2019..

October 30, 2019
·
3 min read
Business

Exelixis Announces Third Quarter 2019 Financial Results and Provides Corporate Update

Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the third quarter of 2019 and provided an update on progress toward fulfilling its key corporate objectives, as well as commercial and clinical development milestones.

October 30, 2019
·
20 min read
Business

Sangamo Therapeutics Announces Third Quarter 2019 Conference Call and Webcast

Sangamo Therapeutics, Inc., a genomic medicine company, announced that the Company has scheduled the release of its third quarter 2019 financial results after the market closes on Wednesday, November 6, 2019.

October 30, 2019
·
1 min read
Pharm Country

Bristol-Myers Squibb to Take Part at the Wolfe Research Healthcare Conference

Bristol-Myers Squibb Company will take part in a fireside chat at the Wolfe Research Healthcare Conference on Wednesday, November 6, 2019, in New York.

October 30, 2019
·
1 min read
Policy

BPTF Testifies Before House Committee on Energy & Commerce About the Pharmaceutical Supply Chain

Task Force Calls for Reasonable Regulations, More Collaboration among Stakeholders

October 30, 2019
·
2 min read
Business

Vanda Pharmaceuticals to Announce Third Quarter 2019 Financial Results on November 6, 2019

Vanda Pharmaceuticals Inc. announced it will release results for the third quarter 2019 and provide a general business overview, on Wednesday, November 6, 2019, after the market closes..

October 30, 2019
·
1 min read
Business

PerkinElmer Announces Financial Results for the Third Quarter of 2019

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, reported financial results for the third quarter ended September 29, 2019.

October 30, 2019
·
34 min read
BioCapital

LUNGevity Launches New Social Media Campaign #ChangeLungCancer

Campaign to raise awareness and drive change as part of Lung Cancer Awareness Month activities

October 30, 2019
·
3 min read
Deals

Cocrystal Pharma, Inc. Announces Proposed Underwritten Public Offering Of Common Stock

COCRYSTAL PHARMA, INC., a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, announced it intends to offer shares of its common stock for sale in an underwritten public offering.

October 30, 2019
·
3 min read